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Objectives: Autologous aphenous vein (ASV) for arterial reconstruction, in vascular limb injuries is the graft material 
of choice. Denatured saphenous vein homograft (DSVH), thanks to its characteristics of readily available autologous 
biological prosthesis, has been proposed as alternative. We report our prospective xperience with DSVH employed for 
arterial reconstruction in civilian limb vascular injuries. 
Materials. From January 1994 to June 1996, DSVH was implanted in 16 male patients (pts.) treated for arterial civilian 
injuries of eight upper limbs and eight lower limbs. 
Methods: In 14 cases it was performed as an interposition graft and in two cases a bypass. We'performed a 30-month 
follow-up and a 20-month mean follow-up. 
Results: Four patients had graft thrombosis at the first postoperative week and were submitted to the replacement of the 
graft with reappearance ofdistal arterial pulse; one of them had graft failure at the fifth postoperative week and because 
the necrosis due to extensive soft tissue damage, he was submitted to limb amputation. 
After 30-months'follow-up weobtained 75% primary patency rate and 93% secondary patency rate. 
Conclusions: In the absence of suitable ASV, DSVH appears to be an interesting alternative for arterial repair in limbs 
in civilian vascular injuries. 
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Introduction 
Vascular trauma is a major source of morbidity and 
mortality. Significant limb loss occurs after injuries to 
peripheral vessels, with an amputation rate of 13% 
reported in Vietnam and 1-28% reported in civilian 
experience, this rate changing as a function of lesion 
complexityJ -3
The successful management of peripheral arterial 
injury requires expeditious diagnosis and treatment. 
Conventional wisdom dictates that autogenous vein 
interposition be used, when direct repair is not feasible, 
because of higher resistance to potential con- 
taminations. 4,5 
However, there are certain conditions in which em- 
ployment of autogenous veins for arterial repair is 
difficult or even impossible. These are: (a) patients 
with critical vascular injuries threatening either life, 
organ or limb and in whom ready arterial flow res- 
titution is imperative; (b) small diameter of available 
* Please address all correspondence to: G. La Barbera, 45, C.so 
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From January 1994 to June 1996, we admitted in our 
institution 43 patients with civilian vascular injuries 
of the limbs. 
We employed DSVH for arterial reconstruction of 
16 male patients. The age ranged from 16 to 79 years 
(mean age: 42 years). Eight patients with upper limbs 
injuries had six brachial lesions, one axillary lesion 
and one radial lesion. The remaining eight patients 
with lower limbs injuries had five popliteal esions 
and three superficial femoral esions. 
autogenous vein; (c) extensive tissue destruction, in- 
volving autogenous veins; (d) sparing of autogenous 
vein capital for further uses .  6 
Thanks to a search for suitable alternatives, ince 
1980, a new vascular graft, namely a homologous 
saphenous vein denatured for at least 6 weeks at a 
temperature of 4 °C, has been available. 7 
This report will detail our experience, including 
careful follow-up and evaluation of the use of DSVH 
for arterial repair in limbs in civilian vascular injuries. 
Materials and Methods 
1078-5884/98/060467+05 $12.00/0 © 1998 W.B. Saunders Company Ltd. 
468 G. La Barbera et al. 
Regarding the criteria of inclusion, three patients 
had haemorrhagic shock, four patients had non-suit- 
able capital vein and in nine patients it was imperative 
to re-establish arterial flow, because of the critical 
general and/or local clinical conditions. 
One patient had an injury secondary to a shotgun 
wound, six patients had an injury due to a stab wound 
and nine patients ustained a blunt trauma. 
The mean delay of ischaemia was 8 h. 
Regarding the clinical severity of limb ischaemia, 
we classified the patients according to the "SVS'/ 
ISCVS ad hoc Committee for standards for lower 
extremity', s One patient had a "viable" limb and 15 
patients had "threatened viable" limbs. 
Eight patients had associated venous injuries: one 
brachial, one common femoral and one superficial 
femoral were repaired by lateral venorrhaphy; one 
brachial and one superficial femoral were ligated; one 
brachial was repaired by debridement and end-to-end 
anastomosis; in one patient it was performed as a 
10 cm DSVH interposition at the articular popliteal 
vein level and in one patient it was performed as a 
5 cm DSVH interposition between cephalic vein and 
axillary vein after brachial vein ligation. 
Four patients had simultaneous orthopaedic skeletal 
treatment: wo external fixation of the thigh-bone, one 
external fixation of the tibia and one internal fixation 
of the tibia. In these patients arterial reconstruction 
always had priority. 
Five patients had nerve lesions treated by ne- 
urorrhaphy. 
Two limbs required simultaneous fasciotomies 
through medial and lateral incisions. 
Nine patients were submitted to preoperative 
arteriography, that showed arterial disruption or oc- 
clusion. At the surgery we noted the following arterial 
findings: three thrombosis, 10 transections, five intimal 
lesions and three disruptions. 
In 14 patients we performed an interposition graft 
(one axillary, five brachial, two radial, two superficial 
femoral and four popliteal) and in two patients a 
superficial femoral-popliteal by-pass, one above and 
one below the knee. 
In one case the proximal anastomosis was placed 
on the proximal axiltary artery, in five cases on the 
proximal brachial artery, in one case on the distal 
brachial artery, in one case on the proximal radial 
artery, in five cases on the distal superficial femoral 
artery and in three cases on the supra-articular pop- 
liteal artery. 
The distal anastomosis was placed in one case on 
the distal axillary artery, in five cases on the distal 
brachial artery, in two cases on the radial artery, in 
two cases on the distal superficial femoral artery, in 
one case on the supra-articular popliteal artery and in 
five cases on infra-articular popliteal artery. 
The mean length of the employed prosthesis was 
6 cm (range: 3-10 cm) and the mean size was 6 mm 
(range: 5-7 mm). 
The patients were not immunosuppressed. 
We performed a 20-month mean follow-up with 
scheduled controls at 1, 6, 12, 18, 24 and 30 months. 
During the follow-up each patient was evaluated by 
arterial pulse palpation, ankle-brachial or wrist- 
brachial measurements, duplex scan examination, 
completed in one case by digital subtraction angio- 
graphy. No one patient died or was lost to follow-up. 
The cumulative patency rate was determined by the 
life table method (Kaplan-Meier). 
Results 
During the first postoperative week, one patient with 
brachial interposition graft, two patients with popliteal 
interposition graft and one patient with superficial 
femoral-popliteal below-knee bypass, underwent 
surgical revision for graft thrombosis due to post- 
traumatic arterial intimal damage not detected by 
visual inspection and left inside in three cases, and an 
anastomotic stenosis in one case, with reappearance 
of distal arterial pulse. At the surgical revision of the 
thrombosis of the superficial femoral-popliteal below- 
knee bypass, we noted the occlusion of the DSVH 
popliteal vein interposition, performed at the same 
time as the arterial reconstruction, and it was treated 
by venous thrombectomy with flow restitution. We 
obtained 75% primary arterial patency rate at 30 
months (Table 1). 
At the fifth postoperative week we had reocclusion 
of the superficial femoral-popliteal bypass and pop- 
liteal vein DSVH interposition, because of gangrene 
following the extensive soft tissue damage, com- 
plicated by infection and haemorrhage due to leaking 
from proximal anastomosis. This patient was sub- 
mitted to major amputation. 
The secondary patency rate at 30 months was 93% 
(Table 2). 
DSVH interposition employed in axillary vein re- 
construction resulted patent at the 30 months control. 
Two patients with superficial femoral interposition 
graft had superficial wound infection and one patient 
with superficial femoral-popliteal below-knee bypass 
had deep infection of the wound, involving the vas- 
cular prosthesis, complicating the extensive soft tissue 
damage. The wound infection rate was 19% and graft 
infection rate 6%. 
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Table 1. Primary patency rate. 
Interval (months) Graft at risk Failed graft 
Patency 
Withdrawn Interval Cumulative 
0-1 16 4 
1-6 12 0 
6-12 12 0 
12-18 11 0 
18-24 8 0 
24-30 2 0 
0 75% 75% 
0 100% 75% 
1 100% 75% 
3 100% 75% 
6 100% 75% 
0 100% 75% 
Table 2. Secondary patency rate. 
Interval (months) Graft at risk 
Patency 
Failed graft Withdrawn Interval Cumulative 
0-1 16 0 
1-6 16 1 
6-12 15 0 
12-18 14 0 
18-24 11 0 
24-30 5 0 
0 100% 100% 
0 93% 93% 
1 100% 93% 
3 100% 93% 
6 100% 93% 
0 100% 93% 
Table 3. Postoperative complications. 
Wound infection 3 
Homograft infection 1 
Aneurysm 0 
Thrombosis 5 
Haemorrhage 1 
Amputation 1 
Fibrotic or aneurysmal degeneration of the graft was 
not observed uring the follow-up (Table 3). 
Discussion 
ASV is generally considered the graft material of choice 
in peripheral vascular econstructions. 9 Conventional 
wisdom dictates the employment of autologous vein, 
moreover in peripheral ischaemia due to a trauma, 
because of the probability of wound contamination. 4's 
In the search for suitable alternatives, ome authors 
evaluated the employment of synthetic vascular graft, 
reporting variable results as function of type of trauma, 
extension of soft tissue damage, anatomic area in- 
volved and calibre of damaged arteries. 5"11'12 
An alternative source of autologous vein, such as 
contralateral saphenous vein or arm veins, were pro- 
posed for revascularisation f chronic limb ischaemia 
in the absence of adequate ipsilateral greater sa- 
phenous vein, 13 but in some injured patients these 
veins are not available because they are involved in 
soft tissue damage, or because of the general and/  
or local critical conditions imposed to avoid time- 
consuming harvesting of the vein, 6 or because the 
greater saphenous vein has a small diameter for im- 
planting. 9 
In these last years there was a renewed interest in 
arterial allograft. The employment of this graft in 
infrageniculate position in patients with critical limb 
ischaemia showed 46% primary patency rate and 50% 
secondary patency rate at 30 months. 14 
Thanks to the search for suitable autologous vein 
alternatives, ince 1980 a new vascular graft, namely 
a homologous vein denatured for at least 6 weeks at 
a temperature of 4 °C, has been available. This graft 
is made by segments of non-varicose saphenous vein, 
harvested after stripping. The best samples are col- 
lected aseptically in vials containing 2 g of Chlor- 
amphenicol per 100 ml of isotonic solution. No ABO 
blood group match or HL-A leucocyte typing is per- 
formed. 7 Initially it was used for secondary access 
surgery. 1° 
The main characteristics of this graft material is to 
be biological, with related advantages in potentially 
contaminated tissue, and to be readily available in 
many sizes and lengths. 
Some authors reported their experience about em- 
ployment of DSVH in arterial revascularisation of
chronic limb ischaemia, with varying results. 
Van Reedt Dortland et al. 15 employed DSVH in 156 
femorodistal rterial reconstructions, obtaining 53% 5- 
year overall cumulative patency rate in patients with 
disabling claudication and 68.4% in patients with crit- 
ical limb ischaemia. 
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Fig. 1. Duplex scan ormal examination f a brachial DSVH inter- 
position at the 24th postoperative month. 
Fig. 2. Digital subtraction arteriography of anormal popliteal DSVH 
interposition, at the sixth postoperative month. 
Van Damne et al. revascularised 12 critical limb 
ischaemia patients, obtaining 50% patency rate at 1 
year. I6 There are no reports in literature concerning 
the use of DSVH in arterial reconstruction of limb 
injuries. 
During a period of 30 months we implanted DSVH 
in eight patients with arterial injuries of superior limbs 
and eight patients with arterial injuries of inferior 
limbs, obtaining 75% primary patency rate at 30 
months and 93% secondary patency rate (Fig. 1). 
Van Reedt Dortland reported 10% aneurysm rate 
during 53 months' follow-up in 176 denatured homo- 
logous vein grafts used for access in the arm, in 
patients with chronic haemodialysis.l° The same author 
obtained 15% cumulative aneurysm rate after 3 years 
and 50% cumulative aneurysm rate after 5 years, in 
156 femorodistal rterial reconstructions for athero- 
sclerotic disease. 15
Sciacca et al. reported 14% aneurysm rate in 21 
patients submitted to lower limb revascularisation 
with homologous vein graft for chronic ischaemia. 18 
The best results obtained in our experience con- 
cerning the patency and the absence of prosthetic 
degeneration could be explained because the injury 
usually acts on a limited length of artery, and requires 
a short segment of graft for revascularisation (Fig. 2). 
DSVH was also used in two patients with associated 
venous lesions. One patient with a popliteal artery 
lesion sustained a contemporary popliteal vein DSVH 
interposition that thrombosed after the first post- 
operative week. This patient was submitted to major 
amputation atthe fifth postoperative week because of 
gangrene of the limb. The other patient had an axillary 
DSVH interposition, which was patent after 30 months. 
Our isolated experience with DSVH in venous re- 
construction does not enable us to make any con- 
clusion, but we can observe that the characteristics of 
good compliance of the vein-homograft wall could be 
an aspect of interest in the reconstruction f the venous 
circulation, which is characterised by slow flow. 
Wound infections are one of the most dangerous 
postoperative complications affecting arterial re- 
constructions in 1-13% of cases, as a function of graft 
material employed, arterial reconstruction technique 
and associated iseases. 17'18'~9 Wound infection rate 
grows from 5-56% in post-traumatic arterial injuries 
reconstructions because of the contamination, the 
extensive soft tissue damage and the associated 
lesions.3-5,6, 20 
In our experience, three patients (18.5%) had in- 
fection of the wound. Two patients (12.5%) had su- 
perficial infection and one patient (6%) had deep 
infection of the wound with extension to the vascular 
graft, followed by haemorrhage from the proximal 
anastomosis. These are encouraging results for the 
employment of biological vascular graft material in 
potentially contaminated post-traumatic arterial re- 
constructions. 
Our results, although obtained from a limited num- 
ber of patients, uggest that DSVH could be considered 
as an alternative graft material in arterial re- 
construction of arterial limb injuries when ASV is not 
available, or when, because of the critical general and/ 
or local clinical conditions, there is not the time for 
harvesting the homologous vein, or when, because of 
the type and magnitude of the trauma, a biological 
graft material is preferred in the aim of more resistance 
to potential contaminations. 
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Larger  ser ies of  pat ients  and  longer  fo l low-up  have  
to be  ga ined  in o rder  to va l idate  our  resu l ts  and  
to de f ine  preservat ion  character ist ics ,  immuno log ica l  
in teract ions  and  c l in ical  use  of th is  condu i t .  
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